ArticleCancer cell international2021

Immune classifier-based signatures provide good prognostic stratification and predict the clinical benefits of immune-based therapies for hepatocellular carcinoma.

Chen Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.